Unlike Alice in Wonderland, simply saying something is so doesn't make it so.<quoted text>
Who gives a crap, that was only an example of one of the things that is wrong with health care.
7 years is too long for a company to get outrageous profits off of medications.
Tax dollars are used to research and develop most medications anyway.
A year with exclusive manufacturing and marketing rights is plenty of time to recoup the costs associated with the research and develop of new medications.
If generics were available after a year the cost of medications would go down tremendously.
“The average drug developed by a major pharmaceutical company costs at least $4 billion, and it can be as much as $11 billion.”
AstraZeneca has spent $12 villion in research money for every new drug developed in the last 15 years. Costs for Amgen have averaged $3.7 billion.
For Amgen, the aver cost is $3.7 billion, according to Bernard Munos at InnoThink. See http://www.fiercebiotech.com/story/high-cost-...
One of the cheapest drugs to be developed was Dificid at $175 million. Sales in the first five months were $24 million. >>>>>Even if development costs were the only costs (no manufacturing costs, no advertising costs, no post-market surveillance, no law suits, etc.), a one year patent term would have resulted in a net loss.<<<<< <<
Even if R&D costs only associated with development of specific drugs brought to market are considered (that is, ignoring the cost of failures), the average cost per drug is over $1 billion.